EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic landscape of a neonatal hypogonadotropic hypogonadism series: Novel variants and phenotypic spectrum

Karine Aouchiche iD, Laure Van Wormhoudt, Kevin Perge iD, Joanne Dornberger, Cindy Colson, Marine Delagrange, Clara Leroy, Jennifer Ledmazel, Vanessa Menut iD, Jessica Benarrous Jaillet, Djamel Bendifallah, Mohamad Hage Chehade und 5 weitere

Journal of Neuroendocrinology · 2026-10 · 38 (10)

DOI: 10.1111/jne.70274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 24.09.2026. Verfasst von Karine Aouchiche und 16 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Marseille (APHM), Department of Paediatrics, Paediatric Endocrinology Unit, CHU Timone Enfants, Marseille, France. Hauptthemen laut MEDLINE: Hypogonadism. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To describe clinical presentation and genetic findings in a cohort of infants with congenital hypogonadotropic hypogonadism (CHH) diagnosed before 2 years of age. From a large cohort of patients who underwent next‐generation sequencing (NGS) for CHH between 2019 and 2025, we identified all patients tested at ≤2 years of age. Genetic analysis consisted of a targeted CHH gene panel, followed by a CPHD‐NGS panel. In one remaining patient with neurodevelopmental defects, whole‐exome sequencing was performed. Phenotypic data were collected through the GENHYPOPIT registry. Twelve male infants (1.5% of the total cohort) met the inclusion criteria; one additional patient via familial screening was included, for a total of 13 patients. All had micropenis; four had associated cryptorchidism (bilateral in half of cases). CHH was biologically confirmed during mini‐puberty in 10 infants, at a median age of 6.8 weeks. Seven of these 10 infants received gonadotropin therapy, at an average of 4.1 months. MRI revealed bilateral olfactory bulb agenesis in five cases. A pathogenic or likely pathogenic variant was identified in 7 of 12 patients (58%), involving TACR3 ( n = 2), ANOS1 , FGFR1 (including two novel variants), SOX10 , GLI2 (through the CPHD panel), and SOX11 (identified by exome sequencing). A genetic cause was identified in 58% of cases, a diagnostic yield higher than reported in pubertal cohorts. Early genetic diagnosis allowed anticipatory monitoring for syndromic manifestations and associated pituitary deficiencies—particularly relevant for FGFR1 and GLI2 variant carriers at risk of CPHD. Our findings support the inclusion of GLI2 and SOX11 in targeted HH gene panels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypogonadismHumansMalePhenotypeInfantInfant, NewbornReceptor, Fibroblast Growth Factor, Type 1Cohort Studies

Stichwörter der Autor:innen

Kallman syndrome, congenital hypogonadotropic hypogonadismgene panel analysisgenetic variants

Substanzen

Receptor, Fibroblast Growth Factor, Type 1FGFR1 protein, human

Autor:innen und Institutionen

  • Assistance Publique-Hôpitaux de Marseille (APHM), Department of Paediatrics, Paediatric Endocrinology Unit, CHU Timone Enfants, Marseille, France.
  • Multidisciplinary Pediatric Department, Aix Marseille Univ, APHM, INSERM, MMG, UMR 1251, La Timone Children's Hospital, Marseille, France.
  • Hospices Civils de Lyon (HCL), Pediatric endocrinology Unit, Hôpital Femme Mère Enfant, Université Claude Bernard Lyon 1, Lyon, France.
  • Department of Pediatric Endocrinology, Genetic, and Gynecology, University Hospital of Toulouse Children's Hospital, Toulouse, France.
  • Department of Genetics, University Hospital of Lille, Lille, France.
  • Department of Pediatrics Endocrinology and Diabetology, University Hospital of Bordeaux, Bordeaux, France.

ORCID-Profile: Karine Aouchiche, Kevin Perge, Vanessa Menut, Anne Barlier, Thierry Brue, Rachel Reynaud, Alexandru Saveanu

Zitieren

APA

Aouchiche, K., Van Wormhoudt, L., Perge, K., Dornberger, J., Colson, C., Delagrange, M., Leroy, C., Ledmazel, J., Menut, V., Jaillet, J. B., Bendifallah, D., Chehade, M. H., Dib, C., Barlier, A., Brue, T., Reynaud, R., & Saveanu, A. (2026). Genetic landscape of a neonatal hypogonadotropic hypogonadism series: Novel variants and phenotypic spectrum. Journal of Neuroendocrinology, 38(10). https://doi.org/10.1111/jne.70274

Vancouver

Aouchiche K, Van Wormhoudt L, Perge K, Dornberger J, Colson C, Delagrange M, et al. Genetic landscape of a neonatal hypogonadotropic hypogonadism series: Novel variants and phenotypic spectrum. Journal of Neuroendocrinology. 2026;38(10). doi:10.1111/jne.70274

BibTeX
@article{Aouchiche2026,
  author = {Aouchiche, Karine and Van Wormhoudt, Laure and Perge, Kevin and Dornberger, Joanne and Colson, Cindy and Delagrange, Marine and Leroy, Clara and Ledmazel, Jennifer and Menut, Vanessa and Jaillet, Jessica Benarrous and Bendifallah, Djamel and Chehade, Mohamad Hage and Dib, Christelle and Barlier, Anne and Brue, Thierry and Reynaud, Rachel and Saveanu, Alexandru},
  title = {Genetic landscape of a neonatal hypogonadotropic hypogonadism series: Novel variants and phenotypic spectrum},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  volume = {38},
  number = {10},
  doi = {10.1111/jne.70274}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche